Home > Boards > US Listed > Biotechs > 22nd Century Group (XXII)

22nd Century Group to Highlight its Reduced Nicotine

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Frenchy2016 Member Profile
 
Followed By 1
Posts 483
Boards Moderated 0
Alias Born 05/06/16
160x600 placeholder
22nd Century’s Vice President of Regulatory Science Publishes Important Public Policy Article GlobeNewswire Inc. - 11/24/2020 11:00:00 AM
22nd Century Group CEO James A. Mish to Speak at Cowen 2020 Boston Cannabis Conference GlobeNewswire Inc. - 11/18/2020 10:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/17/2020 2:32:43 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 11/16/2020 12:03:08 PM
22nd Century Group to Present at the Virtual Fall Investor Summit on November 17 GlobeNewswire Inc. - 11/16/2020 9:45:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/5/2020 7:24:52 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/5/2020 7:16:55 AM
22nd Century Group Reports Financial Results and Business Highlights for the Third Quarter 2020 GlobeNewswire Inc. - 11/5/2020 7:00:00 AM
22nd Century Group to Host Third Quarter 2020 Webcast and Conduct Quarterly Q&A GlobeNewswire Inc. - 10/22/2020 10:00:10 AM
22nd Century Group to Highlight its Reduced Nicotine Technology at The Food and Drug Law Institute’s Tobacco and Nicotine P... GlobeNewswire Inc. - 10/19/2020 10:00:10 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 10/14/2020 3:44:51 PM
22nd Century Group Achieves Breakthrough Technology; Granted New Patent for Reducing Nicotine in Tobacco Plants GlobeNewswire Inc. - 10/14/2020 1:00:10 PM
22nd Century Group Provides Strategy Update Letter from CEO GlobeNewswire Inc. - 9/24/2020 4:05:10 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 9/22/2020 3:14:04 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/17/2020 4:17:13 PM
22nd Century Appoints Leading Plant Biotechnology Expert Dr. Michael Koganov to Board of Directors GlobeNewswire Inc. - 9/17/2020 4:05:10 PM
22nd Century Group to Present at the LD Micro 500 Virtual Conference GlobeNewswire Inc. - 8/27/2020 11:30:10 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 8/6/2020 1:14:22 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/6/2020 7:31:41 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/6/2020 7:01:16 AM
22nd Century Group Reports Financial Results and Business Highlights for the Second Quarter 2020 GlobeNewswire Inc. - 8/6/2020 7:00:10 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 7/31/2020 7:41:24 AM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 7/21/2020 3:46:37 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 7/10/2020 10:40:44 AM
22nd Century Group to Host Webcast of 2020 Second Quarter Results GlobeNewswire Inc. - 7/9/2020 7:00:10 AM
Frenchy2016   Monday, 10/19/20 10:17:10 AM
Re: None
Post # of 51653 
22nd Century Group to Highlight its Reduced Nicotine Technology at The Food and Drug Law Institute’s Tobacco and Nicotine Products Regulation and Policy Conference
The U.S. Food and Drug Administration to provide an update on the Agency’s Comprehensive Plan for Tobacco and Nicotine Regulation


October 19, 2020 10:00 ET | Source: 22nd Century Group, Inc
WILLIAMSVILLE, N.Y., Oct. 19, 2020 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, life science company driven by next generation biotechnology, announced today that Mitchell R. Zeller, director of the Center for Tobacco Products (CTP) at the U.S. Food and Drug Administration (FDA), will provide an update on the FDA’s Comprehensive Plan for Tobacco and Nicotine Products at the Food and Drug Law Institute’s (FDLI) Tobacco and Nicotine Products Regulation and Policy Conference on Wednesday October 21, 2020 at 11:15 a.m. ET.

In addition to Zeller’s presentation, 22nd Century’s Vice President of Regulatory Science, John Pritchard, will participate in the conference’s “Nicotine and Harm Reduction” panel on Thursday, October 22, 2020 at 1:15 p.m. ET. 22nd Century’s Michael Zercher, president and chief operating officer, and Steven Przybyla, general counsel and corporate secretary, will also be in attendance.

https://www.globenewswire.com/news-release/2020/10/19/2110508/0/en/22nd-Century-Group-to-Highlight-its-Reduced-Nicotine-Technology-at-The-Food-and-Drug-Law-Institute-s-Tobacco-and-Nicotine-Products-Regulation-and-Policy-Conference.html

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences